Intech Investment Management LLC Trims Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Intech Investment Management LLC reduced its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 70.1% during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 20,405 shares of the company's stock after selling 47,749 shares during the quarter. Intech Investment Management LLC's holdings in GE HealthCare Technologies were worth $1,915,000 at the end of the most recent reporting period.

A number of other large investors have also recently modified their holdings of GEHC. Pathway Financial Advisers LLC bought a new position in GE HealthCare Technologies in the first quarter valued at $25,000. LGT Financial Advisors LLC boosted its holdings in shares of GE HealthCare Technologies by 1,673.3% in the 3rd quarter. LGT Financial Advisors LLC now owns 266 shares of the company's stock worth $25,000 after purchasing an additional 251 shares in the last quarter. Fred Alger Management LLC bought a new position in shares of GE HealthCare Technologies during the 2nd quarter valued at about $26,000. Capital Performance Advisors LLP purchased a new position in shares of GE HealthCare Technologies during the 3rd quarter valued at about $26,000. Finally, Ashton Thomas Securities LLC bought a new stake in GE HealthCare Technologies in the 3rd quarter worth approximately $26,000. Institutional investors own 82.06% of the company's stock.

Insider Activity at GE HealthCare Technologies

In other GE HealthCare Technologies news, CEO Roland Rott sold 3,577 shares of the company's stock in a transaction that occurred on Wednesday, November 6th. The shares were sold at an average price of $86.48, for a total transaction of $309,338.96. Following the completion of the sale, the chief executive officer now directly owns 24,298 shares of the company's stock, valued at approximately $2,101,291.04. This represents a 12.83 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.27% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

GEHC has been the topic of a number of recent research reports. Wells Fargo & Company increased their price target on shares of GE HealthCare Technologies from $95.00 to $96.00 and gave the company an "overweight" rating in a research report on Thursday, October 31st. Redburn Atlantic upgraded shares of GE HealthCare Technologies to a "strong-buy" rating in a research report on Thursday, August 1st. Stifel Nicolaus upped their price target on shares of GE HealthCare Technologies from $100.00 to $102.00 and gave the company a "buy" rating in a research report on Monday, September 30th. BTIG Research upgraded GE HealthCare Technologies from a "neutral" rating to a "buy" rating and set a $100.00 price objective on the stock in a report on Wednesday, September 18th. Finally, Evercore ISI boosted their target price on GE HealthCare Technologies from $98.00 to $102.00 and gave the company an "outperform" rating in a research note on Tuesday, October 1st. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $94.36.

GE HealthCare Technologies Stock Down 0.2 %

NASDAQ:GEHC traded down $0.16 during mid-day trading on Monday, hitting $82.28. 1,048,795 shares of the company's stock were exchanged, compared to its average volume of 3,070,300. GE HealthCare Technologies Inc. has a one year low of $66.39 and a one year high of $94.55. The company has a debt-to-equity ratio of 1.12, a current ratio of 1.23 and a quick ratio of 0.98. The business has a fifty day moving average price of $88.35 and a 200 day moving average price of $83.62. The company has a market cap of $37.59 billion, a PE ratio of 22.65, a P/E/G ratio of 2.95 and a beta of 1.24.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last issued its earnings results on Wednesday, October 30th. The company reported $1.14 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.06 by $0.08. The firm had revenue of $4.86 billion for the quarter, compared to the consensus estimate of $4.87 billion. GE HealthCare Technologies had a net margin of 8.56% and a return on equity of 25.19%. The business's revenue was up .9% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.99 earnings per share. Equities analysts predict that GE HealthCare Technologies Inc. will post 4.3 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were paid a $0.03 dividend. The ex-dividend date was Friday, October 18th. This represents a $0.12 annualized dividend and a dividend yield of 0.15%. GE HealthCare Technologies's dividend payout ratio is presently 3.30%.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.